Elevated m(6)A RNA modifications associate with immune dysregulation and cancer in people with HIV-1

HIV-1感染者体内m(6)A RNA修饰水平升高与免疫失调和癌症相关。

阅读:1

Abstract

BACKGROUND: N(6)-methyladenosine (m(6)A) modifications of human immunodeficiency virus type 1 (HIV-1) and cellular RNA contribute to regulation of viral and host gene expression. RNA m(6)A dysregulation has been implicated in multiple cancers. However, the role of m(6)A modifications in HIV-1-associated cancers remains unclear. Here, we aim to address this important question using clinical samples. METHODS: Using enzyme-linked immunosorbent assay (ELISA), RNA m(6)A levels were quantified in peripheral blood mononuclear cells (PBMCs) from 43 de-identified people living with HIV-1 (PLWH), comparing those with cancer (n = 15) to those without cancer (n = 28). Correlation analyses were performed to evaluate the associations between m(6)A levels and HIV-1 RNA copies, CD4(+) T-cell counts, and age of PLWH. The mRNA and protein expression of m(6)A regulatory genes was measured by reverse transcription quantitative polymerase chain reaction (RT-qPCR) and Western blot, respectively. Furthermore, quantitative transcriptomic profiling of 84 type I interferon (IFN-I)-responsive genes was performed using an RT-qPCR array. RESULTS: We observed that HIV-1 viral load in the cancer group was higher than the non-cancer group. m(6)A levels of PBMCs were 2.8-fold higher in the cancer group and correlated with the expression of some m(6)A regulatory genes and proteins. Higher m(6)A levels were positively associated with HIV-1 RNA copies and negatively associated with CD4(+) T-cell counts and age. Transcriptomic analysis of 84 IFN-I-responsive genes revealed upregulation of many pro-inflammatory and interferon-stimulated genes, along with downregulation of some genes in PLWH with cancer. CONCLUSIONS: Our findings suggest that HIV-1 infection and cancer-mediated m(6)A reprogramming may contribute to multifaceted chronic immune activation and malignancy in PLWH. Our results also highlight a post-transcriptional mechanism linking HIV-1 persistence to cancer risk. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-026-15874-x.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。